NEOFUNGINE

This brand name is authorized in Tunisia.

Active ingredients

The drug NEOFUNGINE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII I16QD7X297 - NEOMYCIN
 

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.

 
Read more about Neomycin
2
UNII BDF1O1C72E - NYSTATIN
 

Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans.

 
Read more about Nystatin
3
UNII 1ZK20VI6TY - TRIAMCINOLONE
 

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect.

 
Read more about Triamcinolone

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
TN Direction de la Pharmacie et du Médicament 9003601

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.